Navigation Links
Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
Date:5/2/2013

represents adjusted net revenue less

adjusted cost of sales and excludes amortization of acquired

intangibles. Pro forma adjustments for the respective periods

include the following: Adjustment for contract revenue realized at fair value (product sales)

$
4.8$
-Manufacturing and supply contract termination payment (other revenue)

5.0-Acquisition accounting adjustments (cost of sales)

93.5-Acquisition, integration and restructuring

1.0-Operational Excellence Initiative

6.31.7 

Actavis Pharma net revenue, which consists of sales of generics, branded generics and OTC products in the Americas (United States, Canada and Latin America), Europe (Europe, Russia, CIS and Turkey), and the Middle East, Africa, Australia and Asia Pacific (collectively, MEAAP), for the first quarter 2013 increased 37 percent to $1.5 billion primarily due to the acquisition of the Actavis Group in late 2012.  First quarter international net revenue was $608.6 million, up 254 percent from the prior year, primarily as a result of the inclusion of legacy Actavis product sales.  This increase was offset in part by lower sales of the generic version of Lipitor® due to the loss of exclusivity in 2012.

Actavis Pharma R&D investment for the first quarter 2013 increased to $98.8 million and selling and marketing expenses for the first quarter 2013 increased to $159.3 million primarily as a result of the inclusion of legacy Actavis results.

Actavis Pharma's adjusted gross margin increased from 45.1 percent in the first quarter of 2012 to 50.7 percent in the first quarter of 2013, primarily due to the distribution of Lidoderm® and increased margins on our generic version of Concerta® as a result of our contractual arrangement with Ortho-McNeil-Janssen. The prior year gross margin was negatively impacted by higher sales of generic Lipitor® at lower margins.

 
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
2. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
3. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
4. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
5. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
6. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
7. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
8. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
9. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
10. Watson Announces New Name -- Actavis -- for Global Operations
11. Watson and Actavis Receive FTC Second Request
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  As part of its ongoing commitment to ... Marc R. Katz , MD, MPH, cardiac surgeon and ... Vascular Institute implanted the first HeartMate 3 left ventricular ... selected as part of the prestigious MOMENTUM 3™ Clinical ... in the United States—and the first in central Virginia—chosen ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Trastuzumab Market, ... by Genentech, trastuzumab was approved by FDA to be ... trade name of Herceptin, a major product of Roche. ... 6.56 billion around the world. After entering ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and ... the "Radiology Information Systems Market by Type, Deployment ... & Forecast to 2019" report to their offering. ... is estimated at $501.1 Million 2014, and is projected ... of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3
... Care Affiliates ("SCA") today announced that it will host ... on Monday, November 16, 2009, to discuss its 2009 ... be available approximately an hour following the conclusion of ... ) , Please go to SCA,s ...
... Cardiac Science Corporation (Nasdaq: CSCX ... AED ) and diagnostic cardiac monitoring devices, today announced ... 30, 2009, in line with its previous guidance. The Company ... field product update and a non-cash charge of $44.0 million ...
Cached Medicine Technology:Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20
(Date:9/3/2015)... ... 03, 2015 , ... Real Time Pain Relief (RTPR), makers of ... David Mason has signed an official endorsement deal with the company. Originally from New ... his first bull at 15. He is an Australian bull riding champion, following in ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... cost of graduated compression garments. However, graduated compression garments are an effective solution ... and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS for ...
(Date:9/3/2015)... ... ... The first part of a two-part investigative news segment aired last night ... filed against Bard.** These lawsuits, filed by persons and the family members of persons ... recently been consolidated for pretrial proceedings as multidistrict litigation, MDL 2641 Bard IVC Filters ...
(Date:9/3/2015)... (PRWEB) , ... September 03, ... ... Washington, a leading provider of comprehensive eating disorder treatment for adults and ... today that Ileana Calinoiu, MD has joined the medical treatment team. As ...
(Date:9/3/2015)... ... , ... Global Vision , the world leader in the development of ... and artwork inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. ... booth #F33 , Be the first to get a sneak peek of Intelligent Proofreading. ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3
... A recent Special Issue of Business Horizons ... of Business, Indiana University, and published by Elsevier, addresses ... for example, has been at the center of U.S. ... gain bipartisan support from Congress for passage of a ...
... , ... ... ... ...
... ... ... ... ...
... the strokes can recur, usually within a month, according ... the first time, and the child does not receive ... M.D., director of the Pediatric Stroke Program at The ... of arterial ischemic stroke in children at the International ...
... , ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:New Business Horizons special issue on US health care 2Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 2Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 3Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 4Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 5Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 6Health News:The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies' Failure to Provide Adequate Safety Research 7Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 2Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 3Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 4Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 5Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 6Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 7Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 8Health News:Children can have recurrent strokes 2Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 2Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 3Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 4Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 5Health News:LodgeNet Healthcare Deploys Custom Education Solution for M. D. Anderson Cancer Center 2Health News:LodgeNet Healthcare Deploys Custom Education Solution for M. D. Anderson Cancer Center 3Health News:LodgeNet Healthcare Deploys Custom Education Solution for M. D. Anderson Cancer Center 4
... IEC-Innovative Endoscopy Components, ... Arthroscopy Medical Equipment "Made ... Arthroscopes are manufactured according ... featuring the most excellent ...
... Injectable was designed to provide the surgeon with ... of surgical complications during cataract and retinal surgery. ... small and medium sized pupils which allows expansion ... iris sphincter during surgery, and allows the pupil ...
... BV Vertical laminar air flow modules ... or medium size sterile work areas, which ... characteristics of Class100 conditions. The modules can ... especially when it is necessary to create ...
The kneeGRIP™ is designed to secure the position of the lower extremity with the knee flexed....
Medicine Products: